Designing the Next Generation of
3 Primary Breakthroughs For The Treatment Of Mental Health Issues.
IP Protected Bio synthetic pathway for candidate production
Ability to Manufacture and conduct invitro & invivo efficacy testing and conduct human
Portfolio of psycho-targeted biotherapeutics
Pioneering the design of psycho-targeted therapeutics for the improvement of mental and neurological health
Psybio has developed a portfolio of bio-medical chemistry development psycho-targeted compounds for the potential treatment for mental and neurological health.
Psybio was formed to create psycho-targeted biotherapeutics
Dedicated Research and Development Laboratory
Miami University, Oxford, OH
Lawrence Berkley National Lab
Noble Capital Markets
Combined leadership experience with over 50 years in the Biotech Industry
Chief Medical Officer (needs copy here)
Excellent Board of Directors ( needs copy here )